Citizens National Bank Trust Department Astrazeneca PLC Transaction History
Citizens National Bank Trust Department
- $474 Million
- Q3 2024
A detailed history of Citizens National Bank Trust Department transactions in Astrazeneca PLC stock. As of the latest transaction made, Citizens National Bank Trust Department holds 25,665 shares of AZN stock, worth $1.63 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
25,665
Previous 25,690
0.1%
Holding current value
$1.63 Million
Previous $2 Million
0.2%
% of portfolio
0.42%
Previous 0.45%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,358Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$3.99 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.66 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.36 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.33 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.22 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $196B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...